用于宫颈癌筛查的人乳头瘤病毒DNA检测。国际妇产科联盟第26届妇科癌症治疗结果年度报告。 - Suppr

Suppr

超能文献

HPV DNA testing for cervical cancer screening. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.

作者信息

Wright Thomas C

机构信息

Department of Pathology, Columbia University, New York, USA. tcw1columbia.edu

出版信息

Int J Gynaecol Obstet. 2006 Nov;95 Suppl 1:S239-46. doi: 10.1016/S0020-7292(06)60039-8.

DOI:10.1016/S0020-7292(06)60039-8

PMID:17161163

Abstract

摘要

相似文献

HPV DNA testing for cervical cancer screening. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.

Int J Gynaecol Obstet. 2006 Nov;95 Suppl 1:S239-46. doi: 10.1016/S0020-7292(06)60039-8.

HPV test shows low sensitivity of Pap screen in older women.

Lancet Oncol. 2010 Jun;11(6):509-10; author reply 510-1. doi: 10.1016/S1470-2045(10)70064-4.

HPV primary screening for cervical cancer: more pain than protection.

Diagn Cytopathol. 2000 Jun;22(6):333-5. doi: 10.1002/(sici)1097-0339(200006)22:6<333::aid-dc1>3.0.co;2-8.

HPV testing in cervical screening.

Pharmacoepidemiol Drug Saf. 2001 Jan-Feb;10(1):33-6. doi: 10.1002/pds.558.

Could HPV testing become the sole primary cervical screening test?

J Med Screen. 2002;9(2):49-51. doi: 10.1136/jms.9.2.49.

Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.

JAMA. 2002 Oct 9;288(14):1749-57. doi: 10.1001/jama.288.14.1749.

The difference in sensitivity between HPV testing and cytology for detecting current and future CIN2+ increases over time.

Evid Based Med. 2014 Oct;19(5):184. doi: 10.1136/eb-2014-101757. Epub 2014 May 1.

[HPV test replaces Pap test in Uppsala].

Lakartidningen. 2013;110(13-14):695-6.

[Combining high-risk human papillomavirus DNA test and cytological test to detect early cervical dysplasia].

Zhonghua Fu Chan Ke Za Zhi. 2006 Jan;41(1):34-7.

[Evaluation of the effectiveness of BMRT-HPV for cervical cancer screening].

Zhonghua Fu Chan Ke Za Zhi. 2020 Oct 25;55(10):708-715. doi: 10.3760/cma.j.cn112141-20200325-00266.

引用本文的文献

New serum biomarker identification and analysis by mass spectrometry in cervical precancerous lesion and acute cervicitis in South China.

Cancer Manag Res. 2019 Jul 4;11:6151-6162. doi: 10.2147/CMAR.S205052. eCollection 2019.

Serum Immune Profiling for Early Detection of Cervical Disease.

Theranostics. 2017 Aug 23;7(16):3814-3823. doi: 10.7150/thno.21098. eCollection 2017.

Cervical Abnormalities Are More Common among Indigenous than Other Australian Women: A Retrospective Record-Linkage Study, 2000-2011.

PLoS One. 2016 Apr 11;11(4):e0150473. doi: 10.1371/journal.pone.0150473. eCollection 2016.

High Risk HPV E6/E7 Oncoprotein Expression in Women with High Grade Squamous Intraepithelial Lesion.

Rev Bras Ginecol Obstet. 2016 Mar;38(3):154-9. doi: 10.1055/s-0036-1580713. Epub 2016 Mar 29.

Laboratory and clinical aspects of human papillomavirus testing.

Crit Rev Clin Lab Sci. 2012 Jul-Aug;49(4):117-36. doi: 10.3109/10408363.2012.707174.

The nurse's role in the prevention of cervical cancer among underserved and minority populations.

J Community Health. 2009 Apr;34(2):135-43. doi: 10.1007/s10900-008-9134-4.

Comparison of the Third Wave Invader human papillomavirus (HPV) assay and the digene HPV hybrid capture 2 assay for detection of high-risk HPV DNA.

J Clin Microbiol. 2008 May;46(5):1641-6. doi: 10.1128/JCM.01824-07. Epub 2008 Mar 26.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

HPV DNA testing for cervical cancer screening. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.

作者信息

Wright Thomas C

机构信息

Department of Pathology, Columbia University, New York, USA. tcw1columbia.edu

出版信息

Int J Gynaecol Obstet. 2006 Nov;95 Suppl 1:S239-46. doi: 10.1016/S0020-7292(06)60039-8.

DOI:10.1016/S0020-7292(06)60039-8

PMID:17161163

Abstract

摘要

相似文献

HPV DNA testing for cervical cancer screening. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.

Int J Gynaecol Obstet. 2006 Nov;95 Suppl 1:S239-46. doi: 10.1016/S0020-7292(06)60039-8.

HPV test shows low sensitivity of Pap screen in older women.

Lancet Oncol. 2010 Jun;11(6):509-10; author reply 510-1. doi: 10.1016/S1470-2045(10)70064-4.

HPV primary screening for cervical cancer: more pain than protection.

Diagn Cytopathol. 2000 Jun;22(6):333-5. doi: 10.1002/(sici)1097-0339(200006)22:6<333::aid-dc1>3.0.co;2-8.

HPV testing in cervical screening.

Pharmacoepidemiol Drug Saf. 2001 Jan-Feb;10(1):33-6. doi: 10.1002/pds.558.

Could HPV testing become the sole primary cervical screening test?

J Med Screen. 2002;9(2):49-51. doi: 10.1136/jms.9.2.49.

Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.

JAMA. 2002 Oct 9;288(14):1749-57. doi: 10.1001/jama.288.14.1749.

The difference in sensitivity between HPV testing and cytology for detecting current and future CIN2+ increases over time.

Evid Based Med. 2014 Oct;19(5):184. doi: 10.1136/eb-2014-101757. Epub 2014 May 1.

[HPV test replaces Pap test in Uppsala].

Lakartidningen. 2013;110(13-14):695-6.

[Combining high-risk human papillomavirus DNA test and cytological test to detect early cervical dysplasia].

Zhonghua Fu Chan Ke Za Zhi. 2006 Jan;41(1):34-7.

[Evaluation of the effectiveness of BMRT-HPV for cervical cancer screening].

Zhonghua Fu Chan Ke Za Zhi. 2020 Oct 25;55(10):708-715. doi: 10.3760/cma.j.cn112141-20200325-00266.

引用本文的文献

New serum biomarker identification and analysis by mass spectrometry in cervical precancerous lesion and acute cervicitis in South China.

Cancer Manag Res. 2019 Jul 4;11:6151-6162. doi: 10.2147/CMAR.S205052. eCollection 2019.

Serum Immune Profiling for Early Detection of Cervical Disease.

Theranostics. 2017 Aug 23;7(16):3814-3823. doi: 10.7150/thno.21098. eCollection 2017.

Cervical Abnormalities Are More Common among Indigenous than Other Australian Women: A Retrospective Record-Linkage Study, 2000-2011.

PLoS One. 2016 Apr 11;11(4):e0150473. doi: 10.1371/journal.pone.0150473. eCollection 2016.

High Risk HPV E6/E7 Oncoprotein Expression in Women with High Grade Squamous Intraepithelial Lesion.

Rev Bras Ginecol Obstet. 2016 Mar;38(3):154-9. doi: 10.1055/s-0036-1580713. Epub 2016 Mar 29.

Laboratory and clinical aspects of human papillomavirus testing.

Crit Rev Clin Lab Sci. 2012 Jul-Aug;49(4):117-36. doi: 10.3109/10408363.2012.707174.

The nurse's role in the prevention of cervical cancer among underserved and minority populations.

J Community Health. 2009 Apr;34(2):135-43. doi: 10.1007/s10900-008-9134-4.

Comparison of the Third Wave Invader human papillomavirus (HPV) assay and the digene HPV hybrid capture 2 assay for detection of high-risk HPV DNA.

J Clin Microbiol. 2008 May;46(5):1641-6. doi: 10.1128/JCM.01824-07. Epub 2008 Mar 26.